Anaptysbio
ANAB· Manufacturing· Fiscal year ends in June
Daniel Faga is the CEO of Anaptysbio and was paid $6.1M in FY2025 (Jun), down 55%.
Executives3
See all- 1Daniel FagaPresident and Chief Executive Officer and DirectorFY2025
- 2Paul LizzulChief Medical OfficerFY2025
- 3Dennis MulroyChief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allAnaptysbio paid its 3 named executives $10.5M in total in FY2025 (Jun). CEO Daniel Faga was paid $6.1M of that.
| Name | |||
|---|---|---|---|
| Daniel FagaPresident and Chief Executive Officer and Director | |||
| Paul LizzulChief Medical Officer | |||
| Dennis MulroyChief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers15
See allThe FY2025 (Jun) proxy of Anaptysbio names 15 peer companies for pay. Among Anaptysbio and these peers, CEO pay was 2nd highest of 3 and total shareholder return was the highest of 3.
2nd highest of 3in Anaptysbio and its pay peers, FY2025 (Jun) by CEO pay:
1st highest of 3in Anaptysbio and its pay peers, FY2025 (Jun) by total shareholder return:
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board1
See all- Oleg NodelmanDirector · 4 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings3
See all| Proxy statement | DEF 14A | Jun 29, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 29, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 24, 2024 | FY2023 |